Philips introduces integrated Interventional Hemodynamic System with Patient Monitor IntelliVue X3 to improve workflow and patient focus during image-guided procedures at ACC.21

May 14, 2021

Continuous monitoring provides informed, timely clinical decision making and comprehensive, gap-free patient records in the cath lab and beyond

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the integration of its Interventional Hemodynamic System and market-leading portable Patient Monitor IntelliVue X3, providing advanced hemodynamic (blood flow) measurements at the tableside in the cath lab and continuous monitoring of key vital signs throughout the patient journey [1]. The integration provides the opportunity for monitoring during image-guided procedures on the Philips Image Guided Therapy System – Azurion, improving workflow with comprehensive patient records that support timely clinical decision-making during interventional cardiology procedures and beyond. The solution will be introduced at ACC.21, the American College of Cardiology’s 70th Annual Scientific Session and Expo, taking place virtually on May 15-17.

Health systems strive to deliver consistent quality patient care while optimizing the interventional room to treat more patients and accelerate care of the critically ill. Uninterrupted patient monitoring, as patients are moved from holding areas to the interventional room and then on to recovery areas, can help to improve clinical decision making and the timely detection of potential adverse events at every stage of the patient journey. Incorporating a 12-lead diagnostic ECG, the monitor removes the need to re-cable the patient or reconnect monitoring, and can help lead to reduced procedural preparation time, enhanced staff efficiency and ultimately an enhanced patient experience.

“Philips Interventional Hemodynamic System with Patient Monitor IntelliVue X3 is a unique combination made possible by our strengths in patient monitoring and image-guided therapy,” said Ronald Tabaksblat, General Manager Image Guided Therapy Systems at Philips. “Bringing advanced hemodynamic measurements to the tableside as an integrated part of our Azurion image-guided therapy system, it helps allow clinicians to assess the condition of the patient in real time during an intervention, without leaving the sterile field. It also streamlines workflows, providing continuous monitoring of the patient during every step of their care path, enhancing patient safety and confidence.”